Ventilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood Gases

December 16, 2024 updated by: El-Sayed Essam, Cairo University

Effect of Ventilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood Gases in Mechanically Ventilated Patients, a Randomized Clinical Trail

The aim of the current study is to compare the effect of ventilator trigger sensitivity adjustment versus threshold inspiratory muscle training on arterial blood gases in mechanically ventilated patients.

Study Overview

Detailed Description

Failed extubations are not uncommon in most ICUs, the failure rate ranging from 2 to 20%. Since failed extubation is associated with greater hospital morbidity and mortality and longer length of stay, it is imperative to identify screening techniques that minimize the number of failed extubations.

Many studies have been done on the effect of IMT by threshold IMT and adjustment of mechanical ventilator trigger separately, thereby, it is rational to compare between two methods of training to know which is more effective to help in weaning process through its effect on ABGs.

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt
        • Recruiting
        • Kasr Al Ainy School of Medicine
        • Contact:
          • School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Difficult to wean Guillain barre patients who have been on MV for at least 48 hours. Difficult to wean subjects have been defined as those who fail the first spontaneous breathing trial (SBT)and may require up to 3 SBTs or up to 7 d from the first attempt to achieve successful weaning (B´eduneau G. et al.,2017) and (Annia F. et al.,2019).
  2. Age: >18 years.
  3. Both sexes will be included.
  4. Ventilator mode: Pressure support mode with FiO2≤ 0.5, positive end expiratory pressure (PEEP) will be<8-10cm/H2Oand respiratory rate < 25.
  5. Conscious oriented patient with Glasgow coma score ≥13.
  6. Alertness will be titrated to a Riker Sedation Agitation Score of 4.
  7. PH>7.25, arterial oxygen saturation >90%.
  8. Cardiovascular stability.
  9. Maximal inspiratory pressure from 15 to 30 cm H2O and able to trigger spontaneous breaths on ventilator.

Exclusion Criteria:

  1. Persistent hemodynamic instability as life threatening arrhythmias, acute heart failure.
  2. Severe breathlessness, when spontaneously breathing.
  3. Any progressive neuromuscular disease that would interfere with responding to inspiratory muscle training (non-stationary course).
  4. Spinal cord injury.
  5. Skeletal pathology (scoliosis, flail chest, spinal instrumentation) that would seriously impair the movement of the chest wall and ribs.
  6. Patients on heavy sedation and respiratory muscle paralysis.
  7. High peak airway pressure (barotraumas).
  8. BMI ≥ 40.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Threshold inspiratory muscle trainer
Training of the inspiratory muscles by threshold inspiratory muscle trainer.
New techniques to train inspiratory muscles in mechanically ventilated patients
Experimental: Ventilator pressure setting inspiratory muscle training
Training of the inspiratory muscles by ventilator pressure setting.
New techniques to train inspiratory muscles in mechanically ventilated patients
No Intervention: Traditional treatment
Only prescribed medical treatment programme

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PH
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
To measure PH
Pre intervention and immediate post intervention, through study completion, an average of two weeks
PaO2
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
To measure partial pressure of oxygen
Pre intervention and immediate post intervention, through study completion, an average of two weeks
PaCO2
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
To measure partial pressure of carbon dioxide
Pre intervention and immediate post intervention, through study completion, an average of two weeks
HCO3
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
To measure bicarbonate
Pre intervention and immediate post intervention, through study completion, an average of two weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rapid shallow breathing index
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
To measure respiratory endurance
Pre intervention and immediate post intervention, through study completion, an average of two weeks
The Horowitz index
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
To measure PaO2 /FiO2 ratio
Pre intervention and immediate post intervention, through study completion, an average of two weeks
Glasgow coma scale
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
To measure level of consciousness
Pre intervention and immediate post intervention, through study completion, an average of two weeks
Riker Sedation-Agitation Scale
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
Arousal/sedation assessment
Pre intervention and immediate post intervention, through study completion, an average of two weeks
Respiratory rate
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
Number of breath cycles per minute
Pre intervention and immediate post intervention, through study completion, an average of two weeks
Minute ventilation
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
The amount of air that enters the lungs per minute.
Pre intervention and immediate post intervention, through study completion, an average of two weeks
Weaning success rate
Time Frame: post intervention at the end of the study, an average of two weeks
Number of patients weaning from MV
post intervention at the end of the study, an average of two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Elmasry, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

November 12, 2023

First Submitted That Met QC Criteria

December 9, 2023

First Posted (Actual)

December 12, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 16, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Guillain-Barre Syndrome

Clinical Trials on Threshold inspiratory muscle trainer or ventilator pressure setting inspiratory muscle training techniques

Subscribe